{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:29:02Z","timestamp":1787887742818,"version":"build-2784847793"},"reference-count":95,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0700124"],"award-info":[{"award-number":["G0700124"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["L018578"],"award-info":[{"award-number":["L018578"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011703","name":"Yorkshire Cancer Research","doi-asserted-by":"publisher","award":["LPP025"],"award-info":[{"award-number":["LPP025"]}],"id":[{"id":"10.13039\/100011703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009032","name":"Pfizer UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1008716","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T13:48:45Z","timestamp":1597153725000},"page":"e1008716","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza"],"prefix":"10.1371","volume":"16","author":[{"given":"Claire","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayakanth","family":"Kankanala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7752-8987","authenticated-orcid":true,"given":"Toshana L.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4597-5963","authenticated-orcid":true,"given":"Daniel H.","family":"Goldhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4846-9097","authenticated-orcid":true,"given":"Katie","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5689-9076","authenticated-orcid":true,"given":"Marieke","family":"Pingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bentham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1783-6889","authenticated-orcid":true,"given":"Elizabeth","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3485-3111","authenticated-orcid":true,"given":"Eleni","family":"Loundras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Elderfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2244-8642","authenticated-orcid":true,"given":"Jolyon K.","family":"Claridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Stilwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6611-0032","authenticated-orcid":true,"given":"Ranjitha","family":"Tathineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7694-9509","authenticated-orcid":true,"given":"Clive S.","family":"McKimmie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4967-1668","authenticated-orcid":true,"given":"Paul","family":"Targett-Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8204-7608","authenticated-orcid":true,"given":"Jason R.","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy S.","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7233-5243","authenticated-orcid":true,"given":"Stephen","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"issue":"7250","key":"ppat.1008716.ref001","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature08182","article-title":"Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic.","volume":"459","author":"GJ Smith","year":"2009","journal-title":"Nature"},{"issue":"8","key":"ppat.1008716.ref002","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1473-3099(09)70181-1","article-title":"Possible origin of current influenza A H1N1 viruses","volume":"9","author":"H Zhang","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"ppat.1008716.ref003","doi-asserted-by":"crossref","first-page":"RRN1147","DOI":"10.1371\/currents.RRN1147","article-title":"Host Dependent Evolutionary Patterns and the Origin of 2009 H1N1 Pandemic Influenza","volume":"2","author":"A Solovyov","year":"2010","journal-title":"PLoS Curr"},{"issue":"13","key":"ppat.1008716.ref004","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group","volume":"337","author":"FG Hayden","year":"1997","journal-title":"The New England journal of medicine"},{"issue":"18","key":"ppat.1008716.ref005","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199910283411802","article-title":"Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza","volume":"341","author":"FG Hayden","year":"1999","journal-title":"The New England journal of medicine"},{"issue":"13","key":"ppat.1008716.ref006","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","article-title":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment","volume":"282","author":"FG Hayden","year":"1999","journal-title":"Jama"},{"key":"ppat.1008716.ref007","first-page":"450","article-title":"Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections","volume":"7","author":"MM Alame","year":"2016"},{"issue":"2","key":"ppat.1008716.ref008","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1073\/pnas.0909603107","article-title":"T-705 (favipiravir) activity against lethal H5N1 influenza A viruses","volume":"107","author":"M Kiso","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ppat.1008716.ref009","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.01739-09","article-title":"In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses","volume":"54","author":"K Sleeman","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"ppat.1008716.ref010","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents","volume":"379","author":"FG Hayden","year":"2018","journal-title":"N Engl J Med"},{"issue":"38","key":"ppat.1008716.ref011","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.2174\/0929867324666170920165926","article-title":"Influenza Virus: Small Molecule Therapeutics and Mechanisms of Antiviral Resistance","volume":"25","author":"J Han","year":"2018","journal-title":"Curr Med Chem"},{"issue":"24","key":"ppat.1008716.ref012","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.24.30258","article-title":"Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y\/G147R substitution, Japan, March 2016","volume":"21","author":"E Takashita","year":"2016","journal-title":"Euro Surveill"},{"issue":"9","key":"ppat.1008716.ref013","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.3390\/v7092850","volume":"7","author":"TC Li","year":"2015","journal-title":"Viruses."},{"issue":"12","key":"ppat.1008716.ref014","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/infdis\/jiu353","volume":"210","author":"HL Yen","year":"2014","journal-title":"J Infect Dis"},{"issue":"9","key":"ppat.1008716.ref015","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/cid\/cis1220","article-title":"Global assessment of resistance to neuraminidase inhibitors, 2008\u20132011: the Influenza Resistance Information Study (IRIS)","volume":"56","author":"RJ Whitley","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ppat.1008716.ref016","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","article-title":"Influenza virus resistance to neuraminidase inhibitors","volume":"98","author":"M Samson","year":"2013","journal-title":"Antiviral Res"},{"key":"ppat.1008716.ref017","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1038\/ncomms3854","article-title":"virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility","volume":"4","author":"R Hai","year":"2013","journal-title":"Nat Commun"},{"issue":"5983","key":"ppat.1008716.ref018","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.1187816","article-title":"Permissive secondary mutations enable the evolution of influenza oseltamivir resistance","volume":"328","author":"JD Bloom","year":"2010","journal-title":"Science"},{"key":"ppat.1008716.ref019","article-title":"Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza","author":"T Uehara","year":"2019","journal-title":"J Infect Dis"},{"issue":"45","key":"ppat.1008716.ref020","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.1811345115","article-title":"The mechanism of resistance to favipiravir in influenza","volume":"115","author":"DH Goldhill","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ppat.1008716.ref021","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3851\/IMP1538","article-title":"Genomic events contributing to the high prevalence of amantadine-resistant influenza A\/H3N2","volume":"15","author":"H Zaraket","year":"2010","journal-title":"Antiviral therapy"},{"issue":"10","key":"ppat.1008716.ref022","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1128\/AAC.00650-09","article-title":"Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance","volume":"53","author":"Y Furuse","year":"2009","journal-title":"Antimicrob Agents Chemother (Bethesda)"},{"issue":"2","key":"ppat.1008716.ref023","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1124\/mol.119.116640","article-title":"The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers","volume":"96","author":"R Musharrafieh","year":"2019","journal-title":"Mol Pharmacol"},{"issue":"3","key":"ppat.1008716.ref024","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/acs.jmedchem.7b01536","article-title":"In Vitro Pharmacokinetic Optimizations of AM2-S31N Channel Blockers Led to the Discovery of Slow-Binding Inhibitors with Potent Antiviral Activity against Drug-Resistant Influenza A Viruses","volume":"61","author":"Y Wang","year":"2018","journal-title":"J Med Chem"},{"issue":"3","key":"ppat.1008716.ref025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1021\/acsmedchemlett.7b00458","article-title":"Unraveling the Binding, Proton Blockage, and Inhibition of Influenza M2 WT and S31N by Rimantadine Variants","volume":"9","author":"A Drakopoulos","year":"2018","journal-title":"ACS Med Chem Lett"},{"issue":"4","key":"ppat.1008716.ref026","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/acs.jmedchem.6b01852","article-title":"Expeditious Lead Optimization of Isoxazole-Containing Influenza A Virus M2-S31N Inhibitors Using the Suzuki-Miyaura Cross-Coupling Reaction","volume":"60","author":"F Li","year":"2017","journal-title":"J Med Chem"},{"issue":"8","key":"ppat.1008716.ref027","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/pro.2937","article-title":"Crystal structure of the drug-resistant S31N influenza M2 proton channel","volume":"25","author":"JL Thomaston","year":"2016","journal-title":"Protein Sci"},{"issue":"10","key":"ppat.1008716.ref028","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/acsinfecdis.6b00130","article-title":"Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel","volume":"2","author":"F Li","year":"2016","journal-title":"ACS Infect Dis"},{"issue":"3","key":"ppat.1008716.ref029","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1021\/acs.jmedchem.5b01910","article-title":"Discovery of Highly Potent Inhibitors Targeting the Predominant Drug-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel","volume":"59","author":"F Li","year":"2016","journal-title":"J Med Chem"},{"issue":"52","key":"ppat.1008716.ref030","doi-asserted-by":"crossref","first-page":"17987","DOI":"10.1021\/ja508461m","article-title":"Flipping in the Pore: Discovery of Dual Inhibitors That Bind in Different Orientations to the Wild-Type versus the Amantadine-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel","volume":"136","author":"Y Wu","year":"2014","journal-title":"J Am Chem Soc"},{"issue":"7","key":"ppat.1008716.ref031","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1021\/jm301538e","article-title":"Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus","volume":"56","author":"J Wang","year":"2013","journal-title":"J Med Chem"},{"issue":"2","key":"ppat.1008716.ref032","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1006\/viro.1993.1435","article-title":"Role of the M2 protein in influenza virus membrane fusion: effects of amantadine and monensin on fusion kinetics","volume":"195","author":"R Bron","year":"1993","journal-title":"Virology"},{"issue":"3\u20134","key":"ppat.1008716.ref033","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01310675","article-title":"Amantadine inhibits an early, M2 protein-dependent event in the replication cycle of avian influenza (H7) viruses","volume":"119","author":"AP Kendal","year":"1991","journal-title":"Arch Virol"},{"issue":"Pt 4","key":"ppat.1008716.ref034","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1099\/0022-1317-75-4-945","article-title":"Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine","volume":"75","author":"SA Wharton","year":"1994","journal-title":"J Gen Virol"},{"issue":"11","key":"ppat.1008716.ref035","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1074\/jbc.273.11.6518","article-title":"Influenza virus M2 protein slows traffic along the secretory pathway. pH perturbation of acidified compartments affects early Golgi transport steps","volume":"273","author":"JR Henkel","year":"1998","journal-title":"J Biol Chem"},{"issue":"9","key":"ppat.1008716.ref036","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1091\/mbc.9.9.2477","article-title":"Selective perturbation of apical membrane traffic by expression of influenza M2, an acid-activated ion channel, in polarized madin-darby canine kidney cells","volume":"9","author":"JR Henkel","year":"1998","journal-title":"Mol Biol Cell"},{"issue":"4","key":"ppat.1008716.ref037","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1083\/jcb.133.4.733","article-title":"The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus","volume":"133","author":"T Sakaguchi","year":"1996","journal-title":"J Cell Biol"},{"issue":"3","key":"ppat.1008716.ref038","first-page":"171","article-title":"Influenza virus M2 protein and haemagglutinin conformation changes during intracellular transport","volume":"39","author":"F Ciampor","year":"1995","journal-title":"Acta Virol"},{"issue":"1","key":"ppat.1008716.ref039","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0042-6822(92)90730-D","article-title":"Evidence that the amantadine-induced, M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment","volume":"188","author":"F Ciampor","year":"1992","journal-title":"Virology"},{"issue":"2","key":"ppat.1008716.ref040","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1006\/viro.1994.1428","article-title":"Influenza virus M2 protein ion channel activity is not required to maintain the equine-1 hemagglutinin in its native form in infected cells","volume":"202","author":"K Takeuchi","year":"1994","journal-title":"Virology"},{"issue":"2","key":"ppat.1008716.ref041","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1128\/JVI.68.2.911-919.1994","article-title":"Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport","volume":"68","author":"K Takeuchi","year":"1994","journal-title":"J Virol"},{"issue":"3","key":"ppat.1008716.ref042","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","article-title":"Influenza virus M2 protein has ion channel activity","volume":"69","author":"LH Pinto","year":"1992","journal-title":"Cell"},{"issue":"1","key":"ppat.1008716.ref043","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0042-6822(92)91239-Q","article-title":"The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers","volume":"190","author":"KC Duff","year":"1992","journal-title":"Virology"},{"issue":"1","key":"ppat.1008716.ref044","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0042-6822(91)90115-R","article-title":"Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds","volume":"183","author":"LJ Holsinger","year":"1991","journal-title":"Virology"},{"issue":"10","key":"ppat.1008716.ref045","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1073\/pnas.94.10.5000","article-title":"The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer","volume":"94","author":"T Sakaguchi","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"ppat.1008716.ref046","doi-asserted-by":"crossref","first-page":"11301","DOI":"10.1073\/pnas.94.21.11301","article-title":"A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity","volume":"94","author":"LH Pinto","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ppat.1008716.ref047","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0006-3495(96)79690-X","article-title":"Ion selectivity and activation of the M2 ion channel of influenza virus","volume":"70","author":"K Shimbo","year":"1996","journal-title":"Biophys J"},{"issue":"4","key":"ppat.1008716.ref048","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0006-3495(95)80003-2","article-title":"Activation of the M2 ion channel of influenza virus: a role for the transmembrane domain histidine residue","volume":"69","author":"C Wang","year":"1995","journal-title":"Biophys J"},{"issue":"46","key":"ppat.1008716.ref049","doi-asserted-by":"crossref","first-page":"14160","DOI":"10.1021\/bi001799u","article-title":"pH-dependent tetramerization and amantadine binding of the transmembrane helix of M2 from the influenza A virus","volume":"39","author":"D Salom","year":"2000","journal-title":"Biochemistry"},{"key":"ppat.1008716.ref050","article-title":"X-ray Crystal Structure of the Influenza A M2 Proton Channel S31N Mutant in Two Conformational States: An Open and Shut Case","author":"JL Thomaston","year":"2019","journal-title":"J Am Chem Soc"},{"issue":"26","key":"ppat.1008716.ref051","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1021\/jacs.6b03142","article-title":"Solid-State NMR Investigation of the Conformation, Proton Conduction, and Hydration of the Influenza B Virus M2 Transmembrane Proton Channel","volume":"138","author":"JK Williams","year":"2016","journal-title":"J Am Chem Soc"},{"issue":"47","key":"ppat.1008716.ref052","doi-asserted-by":"crossref","first-page":"14877","DOI":"10.1021\/jacs.5b04802","article-title":"Structure and Mechanism of the Influenza A M218-60 Dimer of Dimers","volume":"137","author":"LB Andreas","year":"2015","journal-title":"J Am Chem Soc"},{"issue":"36","key":"ppat.1008716.ref053","doi-asserted-by":"crossref","first-page":"14753","DOI":"10.1021\/ja307453v","article-title":"Hydrogen-bonding partner of the proton-conducting histidine in the influenza M2 proton channel revealed from 1H chemical shifts","volume":"134","author":"M Hong","year":"2012","journal-title":"Journal of the American Chemical Society"},{"issue":"11","key":"ppat.1008716.ref054","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/pro.2158","article-title":"Structural basis for proton conduction and inhibition by the influenza M2 protein","volume":"21","author":"M Hong","year":"2012","journal-title":"Protein science: a publication of the Protein Society"},{"issue":"2","key":"ppat.1008716.ref055","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.coviro.2012.01.005","article-title":"M2 protein from influenza A: from multiple structures to biophysical and functional insights","volume":"2","author":"TA Cross","year":"2012","journal-title":"Curr Opin Virol"},{"issue":"50","key":"ppat.1008716.ref056","doi-asserted-by":"crossref","first-page":"17695","DOI":"10.1021\/ja108458u","article-title":"Kinetic analysis of the M2 proton conduction of the influenza virus","volume":"132","author":"RM Pielak","year":"2010","journal-title":"Journal of the American Chemical Society"},{"issue":"28","key":"ppat.1008716.ref057","doi-asserted-by":"crossref","first-page":"9782","DOI":"10.1021\/ja1027293","article-title":"Proton transport through the influenza A M2 channel: three-dimensional reference interaction site model study","volume":"132","author":"S Phongphanphanee","year":"2010","journal-title":"Journal of the American Chemical Society"},{"issue":"35","key":"ppat.1008716.ref058","doi-asserted-by":"crossref","first-page":"15409","DOI":"10.1073\/pnas.1009997107","article-title":"Proton and cation transport activity of the M2 proton channel from influenza A virus","volume":"107","author":"T Leiding","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6003","key":"ppat.1008716.ref059","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.1191714","article-title":"Mechanisms of proton conduction and gating in influenza M2 proton channels from solid-state NMR","volume":"330","author":"F Hu","year":"2010","journal-title":"Science"},{"issue":"30","key":"ppat.1008716.ref060","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1073\/pnas.0905726106","article-title":"Identification of the functional core of the influenza A virus A\/M2 proton-selective ion channel","volume":"106","author":"C Ma","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7178","key":"ppat.1008716.ref061","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature06531","article-title":"Structure and mechanism of the M2 proton channel of influenza A virus","volume":"451","author":"JR Schnell","year":"2008","journal-title":"Nature"},{"issue":"7178","key":"ppat.1008716.ref062","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature06528","article-title":"Structural basis for the function and inhibition of an influenza virus proton channel","volume":"451","author":"AL Stouffer","year":"2008","journal-title":"Nature"},{"issue":"44","key":"ppat.1008716.ref063","doi-asserted-by":"crossref","first-page":"18775","DOI":"10.1073\/pnas.0910584106","article-title":"An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition","volume":"106","author":"Y Ohigashi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7281","key":"ppat.1008716.ref064","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nature08722","article-title":"Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers","volume":"463","author":"SD Cady","year":"2010","journal-title":"Nature"},{"issue":"9","key":"ppat.1008716.ref065","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tibs.2010.03.006","article-title":"Where does amantadine bind to the influenza virus M2 proton channel","volume":"35","author":"D Kozakov","year":"2010","journal-title":"Trends in biochemical sciences"},{"issue":"30","key":"ppat.1008716.ref066","doi-asserted-by":"crossref","first-page":"11572","DOI":"10.1021\/ja202051n","article-title":"Membrane-dependent effects of a cytoplasmic helix on the structure and drug binding of the influenza virus M2 protein","volume":"133","author":"S Cady","year":"2011","journal-title":"Journal of the American Chemical Society"},{"issue":"12","key":"ppat.1008716.ref067","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1021\/ja102581n","article-title":"Specific binding of adamantane drugs and direction of their polar amines in the pore of the influenza M2 transmembrane domain in lipid bilayers and dodecylphosphocholine micelles determined by NMR spectroscopy","volume":"133","author":"SD Cady","year":"2011","journal-title":"Journal of the American Chemical Society"},{"issue":"1","key":"ppat.1008716.ref068","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbamem.2010.09.014","article-title":"Conformational plasticity of the influenza A M2 transmembrane helix in lipid bilayers under varying pH, drug binding, and membrane thickness","volume":"1808","author":"F Hu","year":"2011","journal-title":"Biochimica et biophysica acta"},{"issue":"31","key":"ppat.1008716.ref069","doi-asserted-by":"crossref","first-page":"13866","DOI":"10.1073\/pnas.1002051107","article-title":"Coexistence of two adamantane binding sites in the influenza A M2 ion channel","volume":"107","author":"MR Rosenberg","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ppat.1008716.ref070","article-title":"Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus","author":"QS Du","year":"2009","journal-title":"J Theor Biol"},{"issue":"32","key":"ppat.1008716.ref071","doi-asserted-by":"crossref","first-page":"10958","DOI":"10.1021\/ja101537p","article-title":"Magic angle spinning NMR investigation of influenza A M2(18\u201360): support for an allosteric mechanism of inhibition","volume":"132","author":"LB Andreas","year":"2010","journal-title":"Journal of the American Chemical Society"},{"issue":"18","key":"ppat.1008716.ref072","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1073\/pnas.0902548106","article-title":"Mechanism of drug inhibition and drug resistance of influenza A M2 channel","volume":"106","author":"RM Pielak","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"ppat.1008716.ref073","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.str.2011.09.003","article-title":"Structural investigation of rimantadine inhibition of the AM2-BM2 chimera channel of influenza viruses","volume":"19","author":"RM Pielak","year":"2011","journal-title":"Structure"},{"issue":"1","key":"ppat.1008716.ref074","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2007.05.001","article-title":"Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system","volume":"76","author":"C StGelais","year":"2007","journal-title":"Antiviral research"},{"issue":"13","key":"ppat.1008716.ref075","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1016\/j.febslet.2010.05.006","article-title":"Direct visualization of the small hydrophobic protein of human respiratory syncytial virus reveals the structural basis for membrane permeability","volume":"584","author":"SD Carter","year":"2010","journal-title":"FEBS Lett"},{"issue":"9","key":"ppat.1008716.ref076","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1128\/JVI.06243-11","article-title":"High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors","volume":"86","author":"LF Wetherill","year":"2012","journal-title":"Journal of virology"},{"issue":"2","key":"ppat.1008716.ref077","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/hep.26685","article-title":"Structure-guided design affirms inhibitors of hepatitis C virus p7 as a viable class of antivirals targeting virion release","volume":"59","author":"TL Foster","year":"2014","journal-title":"Hepatology"},{"key":"ppat.1008716.ref078","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.virol.2013.10.003","article-title":"particles is altered by patient isolate genotype 1a p7 sequences","volume":"448","author":"E Atkins","year":"2014","journal-title":"Virology"},{"issue":"32","key":"ppat.1008716.ref079","doi-asserted-by":"crossref","first-page":"12834","DOI":"10.1021\/ja204969m","article-title":"Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2","volume":"133","author":"J Wang","year":"2011","journal-title":"Journal of the American Chemical Society"},{"issue":"1","key":"ppat.1008716.ref080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.24371","article-title":"Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel","volume":"54","author":"TL Foster","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"ppat.1008716.ref081","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1216526110","article-title":"Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus","volume":"110","author":"J Wang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ppat.1008716.ref082","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/1087057113499631","article-title":"On the Relationship between Molecular Hit Rates in High-Throughput Screening and Molecular Descriptors","volume":"19","author":"M Hansson","year":"2014","journal-title":"J Biomol Screen"},{"issue":"8","key":"ppat.1008716.ref083","doi-asserted-by":"crossref","first-page":"e37095","DOI":"10.1371\/journal.pone.0037095","article-title":"I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y","volume":"7","author":"J LeGoff","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"ppat.1008716.ref084","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jmv.23986","article-title":"pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs","volume":"87","author":"V Correia","year":"2015","journal-title":"J Med Virol"},{"issue":"6003","key":"ppat.1008716.ref085","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.1191750","article-title":"Insight into the mechanism of the influenza A proton channel from a structure in a lipid bilayer","volume":"330","author":"M Sharma","year":"2010","journal-title":"Science"},{"issue":"7","key":"ppat.1008716.ref086","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1021\/acs.chemrev.7b00570","article-title":"Perturbations of Native Membrane Protein Structure in Alkyl Phosphocholine Detergents: A Critical Assessment of NMR and Biophysical Studies","volume":"118","author":"C Chipot","year":"2018","journal-title":"Chem Rev"},{"issue":"Pt 2","key":"ppat.1008716.ref087","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1113\/jphysiol.1996.sp021495","article-title":"Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells","volume":"494","author":"IV Chizhmakov","year":"1996","journal-title":"J Physiol"},{"issue":"9","key":"ppat.1008716.ref088","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1021\/acs.jmedchem.6b01758","article-title":"Slow but Steady Wins the Race: Dissimilarities among New Dual Inhibitors of the Wild-Type and the V27A Mutant M2 Channels of Influenza A Virus","volume":"60","author":"M Barniol-Xicota","year":"2017","journal-title":"J Med Chem"},{"key":"ppat.1008716.ref089","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2017.01.006","article-title":"An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses","volume":"140","author":"Y Hu","year":"2017","journal-title":"Antiviral Res"},{"issue":"27","key":"ppat.1008716.ref090","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1021\/jp800171m","article-title":"A secondary gate as a mechanism for inhibition of the M2 proton channel by amantadine.","volume":"112","author":"M Yi","year":"2008","journal-title":"The journal of physical chemistry B"},{"issue":"1","key":"ppat.1008716.ref091","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbrc.2010.09.008","article-title":"Solution NMR structure of the V27A drug resistant mutant of influenza A M2 channel","volume":"401","author":"RM Pielak","year":"2010","journal-title":"Biochemical and biophysical research communications"},{"issue":"Suppl 2","key":"ppat.1008716.ref092","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2156-16-S2-S3","article-title":"Investigation of a recent rise of dual amantadine-resistance mutations in the influenza A M2 sequence","volume":"16","author":"MG Durrant","year":"2015","journal-title":"BMC Genet"},{"issue":"3","key":"ppat.1008716.ref093","first-page":"188","article-title":"Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31","volume":"90","author":"C Ma","year":"2016","journal-title":"N Channel Blockers. Mol Pharmacol"},{"issue":"3","key":"ppat.1008716.ref094","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"T-C Chou","year":"2006","journal-title":"Pharmacological reviews"},{"issue":"19","key":"ppat.1008716.ref095","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.1128\/JVI.01109-09","article-title":"Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses","volume":"83","author":"B Zhou","year":"2009","journal-title":"J Virol"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T13:50:49Z","timestamp":1597153849000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008716"}},"subtitle":[],"editor":[{"given":"Anice C.","family":"Lowen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":95,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1008716","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/713636","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,11]]}}}